Henan Lingrui Pharmaceutical Co Ltd
SSE:600285
Henan Lingrui Pharmaceutical Co Ltd
Cash from Financing Activities
Henan Lingrui Pharmaceutical Co Ltd
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Henan Lingrui Pharmaceutical Co Ltd
SSE:600285
|
Cash from Financing Activities
-¥332.2m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
N/A
|
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Cash from Financing Activities
-¥753.7m
|
CAGR 3-Years
10%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Cash from Financing Activities
-¥585.4m
|
CAGR 3-Years
2%
|
CAGR 5-Years
-45%
|
CAGR 10-Years
N/A
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Cash from Financing Activities
-¥1.7B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-17%
|
CAGR 10-Years
N/A
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Cash from Financing Activities
-¥2.3B
|
CAGR 3-Years
24%
|
CAGR 5-Years
20%
|
CAGR 10-Years
-21%
|
|
S
|
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
|
Cash from Financing Activities
¥90.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Henan Lingrui Pharmaceutical Co Ltd's Cash from Financing Activities?
Cash from Financing Activities
-332.2m
CNY
Based on the financial report for Sep 30, 2023, Henan Lingrui Pharmaceutical Co Ltd's Cash from Financing Activities amounts to -332.2m CNY.
What is Henan Lingrui Pharmaceutical Co Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
-22%
Over the last year, the Cash from Financing Activities growth was -12%. The average annual Cash from Financing Activities growth rates for Henan Lingrui Pharmaceutical Co Ltd have been -2% over the past three years , -22% over the past five years .